Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Chr. Hansen Holding A/S
  6. Summary
    CHR   DK0060227585

CHR. HANSEN HOLDING A/S

(CHR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Copenhagen
01/10/2022 01/11/2022 01/12/2022 01/13/2022 01/14/2022 Date
508.8(c) 508.4(c) 506.4(c) 540.4(c) 526(c) Last
170 042 204 935 278 961 931 478 520 326 Volume
-2.12% -0.08% -0.39% +6.71% -2.66% Change
More quotes
Estimated financial data (e)
Sales 2022 1 168 M 1 332 M 1 332 M
Net income 2022 234 M 267 M 267 M
Net Debt 2022 879 M 1 003 M 1 003 M
P/E ratio 2022 39,8x
Yield 2022 1,41%
Sales 2023 1 241 M 1 416 M 1 416 M
Net income 2023 259 M 296 M 296 M
Net Debt 2023 833 M 950 M 950 M
P/E ratio 2023 35,8x
Yield 2023 1,60%
Capitalization 9 297 M 10 630 M 10 606 M
EV / Sales 2022 8,71x
EV / Sales 2023 8,16x
Nbr of Employees 3 702
Free-Float 77,8%
More Financials
Company
Chr Hansen Holding A/S is a Denmark-based bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The CompanyÔÇÖs business is divided into three divisions, namely Food Cultures & Enzymes, Health & Nutrition and Natural Colors. The Food Cultures & Enzymes division develops and produces cultures, enzymes and probiotics for the food industry... 
Sector
Food Processing
Calendar
04/06Earnings Release
More about the company
Ratings of Chr. Hansen Holding A/S
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about CHR. HANSEN HOLDING A/S
01/14CHR HANSEN A/S : Q1 Conference call transcript 2021/22
PU
01/13Chr. Hansen Holding A/S Reports Earnings Results for the First Quarter Ended November 3..
CI
01/13European stocks end flat as weak defensives outweigh tech, auto gains
RE
01/13Defensive sectors lead European stocks lower
RE
01/13CHR HANSEN A/S : Q1 Investor presentation 2021/22
PU
01/13CHR HANSEN A/S : Q1 Interim report 2021/22
PU
01/13CHR. HANSEN DELIVERS 9% ORGANIC GROW : Encouraging start to the year
PU
01/13Chr. Hansen Holding A/S Interim Report Q1 2021/22
AQ
2021CHR. HANSEN HOLDING A/S(CPSE : CHR) dropped from OMX Nordic 40 Index
CI
2021CHR HANSEN A/S : AGM 2021 Minutes
PU
2021CHR HANSEN A/S : AGM 2021 Presentation
PU
2021CHR HANSEN A/S : Q1 Aide memoire 2021/22
PU
2021CHR HANSEN A/S : Fermentation-enabled bioprotection secures Chr. Hansen innovation award
PU
2021CHR HANSEN A/S : AGM 2021 Votes cast
PU
2021CHR. HANSEN HOLDING A/S : Ex-dividend day for final dividend
FA
More news
News in other languages on CHR. HANSEN HOLDING A/S
01/13Chr. Hansen Holding A/S publie ses résultats pour le premier trimestre clos le 30 novem..
01/04Début d'année en fanfare
01/04AVIS D'ANALYSTES DU JOUR : Teleperformance, Roche, Sartorius, UMG, Ipsen, Richemont, Lonza..
2021Chr. Hansen Holding A/S approuve un dividende
2021Lonza JV Bacthera, Seres vont produire conjointement un traitement potentiel contre les..
More news
Analyst Recommendations on CHR. HANSEN HOLDING A/S
More recommendations
Chart CHR. HANSEN HOLDING A/S
Duration : Period :
Chr. Hansen Holding A/S Technical Analysis Chart | CHR | DK0060227585 | MarketScreener
Technical analysis trends CHR. HANSEN HOLDING A/S
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Last Close Price 70,61 €
Average target price 72,74 €
Spread / Average Target 3,01%
EPS Revisions
Managers and Directors
Mauricio Graber President & Chief Executive Officer
Lise Skaarup Mortensen Chief Financial Officer & Executive Vice President
Dominique Reiniche Chairman
Thomas Schńfer Chief Scientific Officer & Executive VP
Winnie Hojvang BŘgel VP-Compliance & Corporate Communications